Implanting 3D Bioscaffolds in Rats Works to Trigger FVIII Production

Implanting 3D Bioscaffolds in Rats Works to Trigger FVIII Production

310133

Implanting 3D Bioscaffolds in Rats Works to Trigger FVIII Production

Implanting bioscaffolds — 3D biological scaffolds made up of collagen and other molecules — carrying transformed liver cells into rats successfully triggered the production of factor VIII (FVIII), the clotting protein missing in people with hemophilia A. According to researchers, these bioscaffolds may be a therapeutic alternative to FVIII replacement therapy, a current standard of care treatment for hemophilia A. The new treatment strategy was demonstrated in a study titled “Implanted subcutaneous versus intraperitoneal bioscaffold…

You must be logged in to read/download the full post.